Gastrointestinal stromal tumors: Evolving role of the multidisciplinary team approach in management

Peter Reichardt, Carlo Morosi, Eva Wardelmann, Alessandro Gronchi

Research output: Contribution to journalArticlepeer-review


Gastrointestinal stromal tumors (GISTs) are rare tumors of the GI tract arising from mesenchymal cells. Treatment options include surgical resection and medical therapy with imatinib. A summary of National Comprehensive Cancer Network and European Society of Medical Oncology clinical practice guidelines relating to GIST management are presented here. A multidisciplinary team of physicians is essential to the successful treatment of GIST. Evidence supports multidisciplinary team management with a gastroenterologist, surgeon, medical oncologist, pathologist and radiologist. Consultations between them are recommended to ensure optimal care of patients with GIST. The role for individual core team workers is highlighted. The benefits of multidisciplinary disease management of patients include reducing recurrent disease, optimizing timing of surgery and organ preservation, prolonging survival for the patient and enhancing response to targeted therapies.

Original languageEnglish
Pages (from-to)1053-1068
Number of pages16
JournalExpert Review of Anticancer Therapy
Issue number8
Publication statusPublished - Aug 2012


  • gastrointestinal stromal tumor
  • medical oncologist
  • multidisciplinary team
  • pathologist
  • radiologist
  • surgeon

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology


Dive into the research topics of 'Gastrointestinal stromal tumors: Evolving role of the multidisciplinary team approach in management'. Together they form a unique fingerprint.

Cite this